Medical Device Registration Cost by Country: 2026 Global Comparison Guide

Why Global Registration Costs Vary So Dramatically

Medical device manufacturers expanding internationally face a wide spectrum of registration costs. A Class II device that costs $30,000 to register in the United States (including consulting) can cost $200,000+ in Japan — or as little as $2,000 in Vietnam. Understanding these differences is critical for market prioritization, budget planning, and go-to-market strategy.

Registration costs across countries are driven by four factors:

1. Government/regulatory authority fees — Direct fees charged by the reviewing authority
2. Local representation requirements — Need for in-country agents, sponsors, or authorized representatives
3. Documentation and testing requirements — Technical file preparation, clinical data, type testing
4. Timeline and complexity — Longer reviews mean more consulting hours and overhead

This guide provides a side-by-side comparison of registration costs across 13 major markets, with 2026-specific government fee data and realistic total project cost ranges that include consulting, documentation, and representation.

Quick Comparison: Government Fees by Country

The table below shows government-only fees for a typical Class II / moderate-risk device in each market. These are the direct fees paid to the regulatory authority and do not include consulting, testing, or representation costs.

Country	Authority	Typical Government Fee (Class II)	Review Timeline	Local Rep Required
United States	FDA	$26,067 (510(k) standard) / $6,517 (small biz)	90–120 days (FDA target: 90)	US Agent (foreign mfgrs)
European Union	Notified Body	€15,000–€50,000+ (NB fees vary)	12–18 months	EC REP + PRRC required
Japan	PMDA/MHLW	$3,400–$120,000 by class/pathway	1 week – 36 months	MAH/DMAH required
China	NMPA	€26,500 (Class II) / €38,900 (Class III)	16–36 months	NMPA Legal Agent + DMR
South Korea	MFDS	$73–$1,342 by class	0–80 days	Korea License Holder (KLH)
Brazil	ANVISA	$1,000–$6,000 + $13,500 BGMP	30 days – 12+ months	Brasil License Holder
India	CDSCO	$1,000–$3,000 per site	5–9 months	India Authorized Agent
Australia	TGA	AUD 621–1,187 (Class I–IIb)	4–6 weeks (low risk)	Australian Sponsor
Saudi Arabia	SFDA	SAR 15,000–23,000 ($4,000–$6,133)	35 working days	Authorized Representative
Mexico	COFEPRIS	Variable	30 days (fast-track) – 6 months	Local representative
Canada	Health Canada	Variable by class	60–120 days	MDEL/MDL required
UK	MHRA	New fees from April 2026	30–90 days	UK Responsible Person
Indonesia	MoH/BPOM	Variable by class	3–12 months	Local distributor/agent

Sources: FDA MDUFA FY 2026 Federal Register notice; SFDA fee schedule (SAR rates); NMPA official cost tables; ANVISA fee structure; TGA published fees; PMDA/MHLW schedules; MFDS fee tables; CDSCO Medical Device Rules 2017.

Detailed Cost Breakdown by Market

United States (FDA)

The US remains the world's largest single medical device market, and FDA registration involves some of the highest direct government fees globally — but also one of the most predictable timelines.

FY 2026 FDA Fee Schedule (MDUFA V):

Submission Type	Standard Fee	Small Business Fee
510(k)	$26,067	$6,517
De Novo	$173,782	$43,446
PMA	$579,272	$144,818
513(g)	$7,820	$3,910
Annual Establishment Registration	$11,423	$11,423 (new waiver available)

Total project cost including consulting:

• 510(k): $50,000–$250,000 (FDA fee + test reports + consulting)
• De Novo: $100,000–$2,000,000
• PMA: $500,000–$5,000,000+

Small business savings: Companies with ≤$100M gross revenue qualify for reduced fees. Companies with ≤$30M may get a one-time first PMA fee waiver. NEW in FY 2026: Businesses with ≤$1M revenue may qualify for an establishment registration fee waiver if they can demonstrate financial hardship.

European Union (EU MDR)

EU registration costs are dominated by Notified Body fees, which vary significantly depending on the NB, device classification, and complexity. Under MDR, costs have increased substantially compared to the former MDD system.

Typical Notified Body fee ranges (2026):

Component	Class IIa	Class IIb	Class III
Initial conformity assessment	€10,000–€25,000	€15,000–€40,000	€30,000–€60,000+
Technical documentation review	€5,000–€15,000	€10,000–€30,000	€20,000–€50,000+
QMS audit (initial)	€5,000–€15,000	€5,000–€15,000	€5,000–€15,000
Annual surveillance	€3,000–€8,000	€5,000–€12,000	€8,000–€20,000

Additional mandatory costs:

• EC Authorized Representative: €2,000–€8,000/year
• PRRC (Person Responsible for Regulatory Compliance): internal hire or €5,000–€15,000/year outsourced
• EUDAMED registration: no fee, but administrative effort

Total project cost: €30,000–€120,000+ for CE marking (all classes), plus ongoing annual surveillance costs of €10,000–€30,000/year.

Japan (PMDA)

Japan is one of the most expensive and time-consuming markets for medical device registration, particularly for novel devices requiring full PMDA review (shonin).

Government fees by pathway:

Pathway	Applicable Devices	PMDA/MHLW Fee	Timeline
Pre-Market Submission (Todokede)	Class I	No fee	~1 week
Pre-Market Certification (Ninsho)	Most Class II, some Class III	~$3,400 (RCB fee)	~3 months
Pre-Market Approval (Shonin)	New Class II, III, IV	$20,000–$120,000	6–36 months

Additional costs:

• Japan Marketing Authorization Holder (MAH/DMAH): $10,000–$30,000/year
• Japanese QMS compliance (MHLW Ordinance 169): $10,000–$30,000
• Translation costs (all documents must be in Japanese): $5,000–$20,000

Total project cost: $30,000–$200,000+ depending on classification and novelty.

China (NMPA)

China's NMPA registration is known for lengthy timelines and significant costs, particularly for Class II and III devices that require local clinical trials.

Official NMPA registration fees:

Product Class	Type	Official Cost (EUR)	Timeline
Class I	Initial registration	Free	~1 month
Class II	Initial registration	€26,500 (~$28,850)	16–24 months
Class III	Initial registration	€38,900 (~$42,360)	24–36 months
Class II/III	Extension (every 5 years)	€5,150	5–7 months

Additional costs:

• NMPA Legal Agent: $5,000–$15,000/year
• Domestic Market Record (DMR) holder
• Type testing at Chinese laboratories: $10,000–$50,000
• Local clinical trials (if required): $100,000–$500,000+

Total project cost: $30,000–$500,000+ (lower if leveraging foreign clinical data accepted by NMPA).

South Korea (MFDS)

South Korea offers relatively low government fees but requires Korean-language submissions and a local Korea License Holder (KLH).

MFDS government fees:

Classification	Processing Time	Official Fee
Class I	0 days (notification)	$73 (₩85,000)
Class II with SE	25 days	$112 (₩130,000)
Class III/IV with SE	65 days	$617 (₩719,000)
Class II/III/IV without SE	80 days	$1,283 (₩1,495,000)

Additional costs:

• Korea License Holder (KLH): $5,000–$15,000/year
• KGMP certificate: $10,000–$25,000 (including audit preparation)
• Korean-language documentation: $3,000–$10,000

Total project cost: $20,000–$50,000.

Brazil (ANVISA)

Brazil uses a unique classification system with RDC 751/2022. ANVISA costs vary significantly depending on whether BGMP (Brazilian GMP) certification is required.

ANVISA registration fees:

Classification	Upfront Costs	Timeline
Class I/II (notification)	$1,000–$2,000 per notification	~30 days
Class III/IV (full registration)	$3,000–$6,000 + BGMP	6–12+ months
BGMP inspection	$13,500	Every 2–4 years

Ongoing costs: $1,000–$3,000/year per product for in-country representation, letters of importation, PMS, and vigilance.

Total project cost: $10,000–$40,000 (higher if BGMP inspection is required).

India (CDSCO)

India offers one of the most cost-effective registration pathways among major markets, with relatively low government fees under the Medical Devices Rules, 2017.

Registration costs:

• Government fees: $1,000–$3,000 per site
• India Authorized Agent: $2,000–$5,000/year
• Timeline: 5 months (Class A/B) to 9+ months (Class C/D)

Total project cost: $10,000–$30,000.

Australia (TGA)

Australia's TGA offers a streamlined registration process, particularly for devices that already have approval from a reference regulatory authority (FDA, EU NB, Health Canada, etc.).

TGA government fees (2026):

Device Class	Application Fee (AUD)	Approximate USD
Class I	AUD 621	~$416
Class IIa / IIb	AUD 1,187	~$795
Class III / AIMD	Higher (case-by-case)	~$1,000–$3,000

Additional costs:

• Australian Sponsor: $2,000–$5,000/year
• Conformity assessment (if no reference approval): $5,000–$15,000

Total project cost: $4,000–$8,000 (up to $15,000 for Class III without reference approval).

Saudi Arabia (SFDA)

Saudi Arabia uses a classification system (Class A–D) aligned with the EU MDR framework. The SFDA has published a clear fee schedule.

SFDA registration fees (2025–2026):

Device Class	SFDA Fee (SAR)	Approximate USD	Review Time
Class A	SAR 15,000	~$4,000	35 working days
Class B	SAR 19,000	~$5,067	35 working days
Class C/D	SAR 21,000–23,000	~$5,600–$6,133	35 working days
MDMA Renewal	SAR 5,000	~$1,333	—
Major update	SAR 5,000	~$1,333	—

Additional costs:

• Authorized Representative: $3,000–$8,000/year
• GMP inspection (if required): SAR 10,000 per certificate

Total project cost: $15,000–$30,000.

Mexico (COFEPRIS)

Mexico offers a 30-day fast-track approval for devices already cleared by FDA, Health Canada, or a EU Notified Body (under MDSAP).

Costs:

• Government fees: Variable
• Local representative: $3,000–$8,000/year
• Fast-track (with reference country approval): 30 days, $5,000–$15,000 total
• Standard route: 6+ months, $10,000–$25,000 total

United Kingdom (MHRA)

Post-Brexit, the UK requires UKCA marking (or CE marking during the transition period) and a UK Responsible Person.

Key updates for 2026:

• MHRA introduced new annual registration fees from April 2026 for post-market surveillance activities
• UK Responsible Person: $3,000–$8,000/year
• Total project cost: $10,000–$30,000

Canada (Health Canada)

Canada requires an MDEL (Medical Device Establishment License) for importers/distributors and an MDL (Medical Device License) for Class II–IV devices.

Costs:

• Government fees: Variable by device class
• Review timeline: 60–120 days (Class II–IV)
• Total project cost: $10,000–$30,000

Indonesia (MoH/BPOM)

Indonesia uses a classification system aligned with ASEAN harmonization, requiring local distributor registration.

Costs:

• Government fees: Variable by class
• Local distributor/agent required
• Halal certification may be required
• Total project cost: $5,000–$20,000
• Timeline: 3–12 months

Registration Cost Comparison: Summary Matrix

For a typical Class II / moderate-risk medical device (equivalent classification in each market), here is the realistic total project cost range including government fees, consulting, representation, and documentation:

Country	Total Project Cost	Timeline	Complexity
Vietnam	$2,000–$10,000	3–6 months	Low
Australia	$4,000–$15,000	4–6 weeks	Low
India	$10,000–$30,000	5–9 months	Medium
Mexico	$10,000–$25,000	30 days – 6 months	Medium
Brazil	$10,000–$40,000	30 days – 12 months	Medium–High
UK	$10,000–$30,000	30–90 days	Medium
Canada	$10,000–$30,000	60–120 days	Medium
Saudi Arabia	$15,000–$30,000	35 working days	Medium
South Korea	$20,000–$50,000	0–80 days	Medium
United States	$50,000–$250,000	90–120 days	Medium–High
European Union	$30,000–$120,000+	12–18 months	High
Indonesia	$5,000–$20,000	3–12 months	Medium
China	$30,000–$500,000+	16–36 months	Very High
Japan	$30,000–$200,000+	1 week – 36 months	Very High

Factors That Affect Your Registration Cost

1. Device Classification

Higher-risk devices cost significantly more across all markets. A Class I device may cost nothing to register in Japan, while a Class III/IV device can exceed $120,000 in PMDA fees alone.

2. Novelty vs. Predicate Devices

Devices with established predicates (substantially equivalent to existing marketed products) are cheaper and faster to register everywhere. Novel devices requiring clinical evidence dramatically increase costs.

3. Existing Approvals (Leverage Strategy)

Many countries accept or reference approvals from other regulatory authorities. This can dramatically reduce costs and timelines:

• Australia TGA accepts FDA, EU, Health Canada, and Japan approvals
• Saudi Arabia SFDA accepts MDSAP certificates
• Mexico COFEPRIS accepts FDA, Health Canada, and EU NB approvals
• Brazil ANVISA has expedited pathways for MDSAP-certified manufacturers

4. Consulting Fees by Region

Regulatory consulting hourly rates vary significantly by geography. Based on published fee schedules (Source: OMC Medical, Q3 2025):

Region	Tier 1 Rate	Tier 2 Rate	Tier 3 Rate
US (FDA)	$375–$450/hr	$275–$325/hr	$150–$200/hr
EU (EMA/NB)	$350–$425/hr	$260–$315/hr	$140–$185/hr
Japan (PMDA)	$360–$430/hr	$265–$320/hr	$145–$190/hr
China (NMPA)	$335–$395/hr	$250–$300/hr	$135–$180/hr
India (CDSCO)	$290–$340/hr	$210–$260/hr	$110–$150/hr
Brazil (ANVISA)	$315–$375/hr	$235–$285/hr	$125–$170/hr

5. Local Representation Costs

Almost every market requires a local in-country representative. Annual costs typically range from $2,000 (India, Australia) to $30,000+ (Japan MAH). This is an ongoing, recurring expense that must be budgeted for the entire market lifecycle.

How to Prioritize Markets by ROI

Not all markets deliver equal return on investment. Consider these factors when building your global registration roadmap:

Fastest Time-to-Market (< 6 months)

1. Australia — 4–6 weeks if leveraging FDA/EU approval
2. Saudi Arabia — 35 working days
3. South Korea — Class I is instant; Class II with SE is 25 days
4. Mexico — 30 days with fast-track
5. Brazil — 30 days for Class I/II notifications

Best Cost-to-Market-Size Ratio

1. United States — Highest fees, but the $500B+ device market justifies the investment
2. European Union — Large aggregate market across 27 member states
3. Australia — Very low cost, high-value healthcare market
4. India — Low cost, rapidly growing market

Markets Requiring the Most Caution (Highest Cost/Risk)

1. China — Long timelines, potential local clinical trials, IP considerations
2. Japan — Highest per-device cost, complex MAH requirements
3. Brazil — BGMP inspection requirement adds significant cost and complexity

Planning Your Global Registration Budget

Recommended Budget Allocation

For a mid-size medical device company planning entry into 5–8 markets simultaneously:

Budget Category	Typical Allocation
Regulatory consulting & submissions	40–50%
Government/regulatory fees	15–20%
Local representation (annual)	10–15%
Testing and type examination	10–15%
Translation and documentation	5–10%
Travel, audits, and miscellaneous	5%

Cost-Saving Strategies

1. Leverage reference country approvals — Start with FDA or EU MDR, then use those approvals to fast-track Australia, Saudi Arabia, Mexico, and others
2. Bundle registrations — Register multiple devices simultaneously to amortize fixed costs (representation, QMS audits)
3. Use MDSAP — A single MDSAP audit satisfies requirements for US, Canada, Brazil, Japan, and Australia
4. Negotiate NB fees — EU Notified Body fees are negotiable; get quotes from multiple NBs
5. Qualify for small business status — FDA SBD program can reduce 510(k) fees by 75%

Key Takeaways

• Government fees range from $0 (Japan Class I) to $579,272 (FDA PMA) — know the fee structure before committing to a market
• Total project costs are typically 2–10x the government fee due to consulting, documentation, and representation
• Japan and China are the most expensive and time-consuming markets — plan 2–3 years for these
• Australia and Saudi Arabia offer the best cost-to-speed ratio for companies with existing approvals
• The FDA's small business program can save up to $434,454 on a first PMA — check eligibility early
• Local representation is a perpetual cost — budget $2,000–$30,000/year per market indefinitely